Search

Search Constraints

You searched for: Author/Creator Belenkov, Yury

Search Results

1. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society. (6th August 2020)

2. Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge. (21st February 2018)

3. COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology. (5th December 2021)

4. Modern‐day cardio‐oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'. (20th December 2018)

5. Recent advances in cardio‐oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'. (28th December 2019)

6. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC). (21st August 2020)

7. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology. (20th October 2020)